Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Effects of Aryl Hydrocarbon Receptor Deficiency on PCB-77-Induced Impairment of Glucose Homeostasis during Weight Loss in Male and Female Obese Mice.

Jackson EN, Thatcher SE, Larian N, English V, Soman S, Morris AJ, Weng J, Stromberg A, Swanson HI, Pearson K, Cassis LA.

Environ Health Perspect. 2019 Jul;127(7):77004. doi: 10.1289/EHP4133. Epub 2019 Jul 15.

2.

Current and Emerging Uses of Statins in Clinical Therapeutics: A Review.

Davies JT, Delfino SF, Feinberg CE, Johnson MF, Nappi VL, Olinger JT, Schwab AP, Swanson HI.

Lipid Insights. 2016 Nov 14;9:13-29. eCollection 2016. Review.

3.

Development of a Course-Based Undergraduate Research Experience to Introduce Drug-Receptor Concepts.

Swanson HI, Sarge OP, Rodrigo-Peiris T, Xiang L, Cassone VM.

J Med Educ Curric Dev. 2016 May 12;3. pii: JMECD.S31233. doi: 10.4137/JMECD.S31233. eCollection 2016 Jan-Dec.

4.

Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?

Swanson HI.

Drug Metab Dispos. 2015 Oct;43(10):1499-504. doi: 10.1124/dmd.115.065714. Epub 2015 Aug 10. Review.

5.

Impact of apigenin and kaempferol on human head and neck squamous cell carcinoma.

Swanson HI, Choi EY, Helton WB, Gairola CG, Valentino J.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Feb;117(2):214-20. doi: 10.1016/j.oooo.2013.10.012. Epub 2013 Nov 5.

6.

Coplanar polychlorinated biphenyls impair glucose homeostasis in lean C57BL/6 mice and mitigate beneficial effects of weight loss on glucose homeostasis in obese mice.

Baker NA, Karounos M, English V, Fang J, Wei Y, Stromberg A, Sunkara M, Morris AJ, Swanson HI, Cassis LA.

Environ Health Perspect. 2013 Jan;121(1):105-10. doi: 10.1289/ehp.1205421. Epub 2012 Oct 24.

7.

Role of nuclear receptors in lipid dysfunction and obesity-related diseases.

Swanson HI, Wada T, Xie W, Renga B, Zampella A, Distrutti E, Fiorucci S, Kong B, Thomas AM, Guo GL, Narayanan R, Yepuru M, Dalton JT, Chiang JY.

Drug Metab Dispos. 2013 Jan;41(1):1-11. doi: 10.1124/dmd.112.048694. Epub 2012 Oct 4.

8.

Development of novel CH223191-based antagonists of the aryl hydrocarbon receptor.

Choi EY, Lee H, Dingle RW, Kim KB, Swanson HI.

Mol Pharmacol. 2012 Jan;81(1):3-11. doi: 10.1124/mol.111.073643. Epub 2011 Oct 3.

9.

Impact of 2,3,7,8-tetrachlorodibenzo-p-dioxin on cutaneous wound healing.

Moirangthem V, Katz WS, Su W, Choi EY, Dingle RW, Zeigler GM, Everson WV, Jennings CD, Gong M, Swanson HI.

Exp Toxicol Pathol. 2013 Jan;65(1-2):61-7. doi: 10.1016/j.etp.2011.06.001. Epub 2011 Jul 2.

10.

Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy.

Swanson HI, Njar VC, Yu Z, Castro DJ, Gonzalez FJ, Williams DE, Huang Y, Kong AN, Doloff JC, Ma J, Waxman DJ, Scott EE.

Drug Metab Dispos. 2010 Apr;38(4):539-44. doi: 10.1124/dmd.109.031351.

11.

Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event?

Ray S, Swanson HI.

Biochem Pharmacol. 2009 Feb 15;77(4):681-8. doi: 10.1016/j.bcp.2008.11.022. Epub 2008 Nov 27. Review.

12.

Development of an aryl hydrocarbon receptor antagonist using the proteolysis-targeting chimeric molecules approach: a potential tool for chemoprevention.

Puppala D, Lee H, Kim KB, Swanson HI.

Mol Pharmacol. 2008 Apr;73(4):1064-71. doi: 10.1124/mol.107.040840. Epub 2008 Jan 4.

PMID:
18178667
13.

Cigarette smoke condensate and dioxin suppress culture shock induced senescence in normal human oral keratinocytes.

Zhang L, Wu R, Dingle RW, Gairola CG, Valentino J, Swanson HI.

Oral Oncol. 2007 Aug;43(7):693-700. Epub 2006 Oct 25.

14.
15.

Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation.

Puppala D, Gairola CG, Swanson HI.

Carcinogenesis. 2007 Mar;28(3):639-47. Epub 2006 Sep 28.

PMID:
17012224
17.

The p53 inhibitor pifithrin-alpha is a potent agonist of the aryl hydrocarbon receptor.

Hoagland MS, Hoagland EM, Swanson HI.

J Pharmacol Exp Ther. 2005 Aug;314(2):603-10. Epub 2005 Apr 20.

PMID:
15843497
18.

Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective.

Swanson HI.

Chem Biol Interact. 2004 Oct 15;149(2-3):69-79. Review.

PMID:
15501429
19.

Dioxin-induced immortalization of normal human keratinocytes and silencing of p53 and p16INK4a.

Ray SS, Swanson HI.

J Biol Chem. 2004 Jun 25;279(26):27187-93. Epub 2004 Apr 24.

20.

Alteration of keratinocyte differentiation and senescence by the tumor promoter dioxin.

Ray SS, Swanson HI.

Toxicol Appl Pharmacol. 2003 Oct 15;192(2):131-45.

PMID:
14550747
21.

Use of [125I]4'-iodoflavone as a tool to characterize ligand-dependent differences in Ah receptor behavior.

Swanson HI, Whitelaw ML, Petrulis JR, Perdew GH.

J Biochem Mol Toxicol. 2002;16(6):298-310.

PMID:
12481305
22.

DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation.

Swanson HI.

Chem Biol Interact. 2002 Sep 20;141(1-2):63-76. Review.

PMID:
12213385
23.
24.

Molecular characterization and developmental expression of the aryl hydrocarbon receptor from the chick embryo.

Walker MK, Heid SE, Smith SM, Swanson HI.

Comp Biochem Physiol C Toxicol Pharmacol. 2000 Jul;126(3):305-19.

PMID:
11048681
25.

The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1.

Klinge CM, Kaur K, Swanson HI.

Arch Biochem Biophys. 2000 Jan 1;373(1):163-74.

PMID:
10620335
26.

The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.

Klinge CM, Bowers JL, Kulakosky PC, Kamboj KK, Swanson HI.

Mol Cell Endocrinol. 1999 Nov 25;157(1-2):105-19.

PMID:
10619402
27.
28.
29.

The aryl hydrocarbon receptor interacts with transcription factor IIB.

Swanson HI, Yang JH.

Mol Pharmacol. 1998 Oct;54(4):671-7.

PMID:
9765510
30.

The dose-response model for dioxin.

Byrd DM 3rd, Allen DO, Beamer RL, Besch HR Jr, Bylund DB, Doull J, Fleming WW, Fries A, Guengerich FP, Hornbrook R, Lasagna L, Lum BK, Michaelis EK, Morgan ET, Poland A, Rozman KK, Smith JB, Swanson HI, Waddell W, Wilson JD.

Risk Anal. 1998 Feb;18(1):1-2. No abstract available.

PMID:
9556441
31.
32.

DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins.

Swanson HI, Chan WK, Bradfield CA.

J Biol Chem. 1995 Nov 3;270(44):26292-302.

33.
34.

Protein kinase C is not involved in Ah receptor transformation and DNA binding.

Schafer MW, Madhukar BV, Swanson HI, Tullis K, Denison MS.

Arch Biochem Biophys. 1993 Dec;307(2):267-71.

PMID:
7506016
35.
36.

Cloning and expression of a human Ah receptor cDNA.

Dolwick KM, Schmidt JV, Carver LA, Swanson HI, Bradfield CA.

Mol Pharmacol. 1993 Nov;44(5):911-7.

PMID:
8246913
37.

The AH-receptor: genetics, structure and function.

Swanson HI, Bradfield CA.

Pharmacogenetics. 1993 Oct;3(5):213-30. Review.

PMID:
8287061
38.

In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition.

Dolwick KM, Swanson HI, Bradfield CA.

Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8566-70.

39.
40.
41.

Mechanisms of anti-carcinogenesis by indole-3-carbinol. Studies of enzyme induction, electrophile-scavenging, and inhibition of aflatoxin B1 activation.

Fong AT, Swanson HI, Dashwood RH, Williams DE, Hendricks JD, Bailey GS.

Biochem Pharmacol. 1990 Jan 1;39(1):19-26.

Supplemental Content

Loading ...
Support Center